Skip to main contentSkip to navigation
Sirius Investors
BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
NASDAQHealthcare

BVXV Financial Statements & Analysis

Complete financial statements for BVXV including income statement, balance sheet, and cash flow statement. Analyze BVXV's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
0.0%
Net Income
695.5%
Gross Margin
0.0%
Operating Margin
0.0%

Balance Sheet

Current Ratio
-3.9%
Debt to Equity
28.5%
Asset Turnover
0.0%

Cash Flow

Operating Cash Flow
-138.3%
Net Cash Flow
-4.8%
Free Cash Flow
-739.5%
Cash Flow to Debt
-136.2%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q1 '23TTM Q2 '23ChangeImpact
Revenue000.0%
Gross Profit2.02M2.02M0.0%
Operating Income-16.90M-8.71M48.4%
Net Income-1.31M7.78M695.5%
EPS-0.150.75609.1%
EBITDA-4.80M1.04M121.7%
Gross Margin0.00%0.00%0.0%
Operating Margin0.00%0.00%0.0%
Net Income Margin0.00%0.00%0.0%
R&D Expenses14.28M9.24M35.3%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '23TTM Q1 '23TTM Q4 '22TTM Q3 '22TTM Q2 '22
Revenue000
Gross Profit2.02M2.02M0
Operating Income-8.71M-16.90M-22.00M
Net Income7.78M-1.31M-6.88M
EPS0.75-0.15-0.91
EBITDA1.04M-4.80M-7.61M
Gross Margin0.00%0.00%0.00%
Operating Margin0.00%0.00%0.00%
Net Income Margin0.00%0.00%0.00%
R&D Expenses9.24M14.28M15.94M

Our detailed financial analysis helps investors understand BVXV's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track BVXV's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into BVXV's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
BiondVax Pharmaceuticals Ltd. (BVXV) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors